Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $10.13 and traded as low as $7.87. Bavarian Nordic A/S shares last traded at $8.05, with a volume of 7,983 shares traded.
Bavarian Nordic A/S Price Performance
The firm has a market capitalization of $1.90 billion, a price-to-earnings ratio of 11.67 and a beta of 1.68. The business has a 50 day moving average of $8.98 and a 200 day moving average of $10.13.
Bavarian Nordic A/S Company Profile
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Featured Stories
- Five stocks we like better than Bavarian Nordic A/S
- Canada Bond Market Holiday: How to Invest and Trade
- 3 Must-Have ETFs Set to Dominate This Quarter
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Seeking Stability? These 3 Stocks Offer Strong Potential
- What is the Nasdaq? Complete Overview with History
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Bavarian Nordic A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic A/S and related companies with MarketBeat.com's FREE daily email newsletter.
